Eiger BioPharmaceuticals, Inc. (EIGRQ)
USD 8.5
(6.25%)
USD 8.5
(6.25%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 86.78 Million USD | -16.19% |
| 2022 | 103.54 Million USD | 18.29% |
| 2021 | 87.53 Million USD | 42.33% |
| 2020 | 61.5 Million USD | -10.11% |
| 2019 | 68.41 Million USD | 34.17% |
| 2018 | 50.99 Million USD | 22.94% |
| 2017 | 41.47 Million USD | -10.02% |
| 2016 | 46.09 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 26.07 Million USD | -2.0% |
| 2023 Q4 | 16.13 Million USD | -18.6% |
| 2023 FY | 86.78 Million USD | -16.19% |
| 2023 Q2 | 24.75 Million USD | -5.07% |
| 2023 Q3 | 19.82 Million USD | -19.91% |
| 2022 Q3 | 28.95 Million USD | 21.58% |
| 2022 Q1 | 24.17 Million USD | 0.86% |
| 2022 FY | 103.54 Million USD | 18.29% |
| 2022 Q4 | 26.6 Million USD | -8.1% |
| 2022 Q2 | 23.81 Million USD | -1.52% |
| 2021 Q4 | 23.97 Million USD | -1.66% |
| 2021 FY | 87.53 Million USD | 42.33% |
| 2021 Q3 | 24.37 Million USD | 22.05% |
| 2021 Q2 | 19.97 Million USD | 0.0% |
| 2020 FY | 61.5 Million USD | -10.11% |
| 2019 FY | 68.41 Million USD | 34.17% |
| 2018 FY | 50.99 Million USD | 22.94% |
| 2017 FY | 41.47 Million USD | -10.02% |
| 2016 FY | 46.09 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -6398.651% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -1621.227% |
| Evofem Biosciences, Inc. | 29.55 Million USD | -193.659% |
| Nascent Biotech, Inc. | 2.22 Million USD | -3791.915% |
| Rebus Holdings, Inc. | 664 Thousand USD | -12970.03% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | -132.944% |
| Qrons Inc. | 643.67 Thousand USD | -13382.694% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -22177.355% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | -51.088% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -20787.939% |
| Skye Bioscience, Inc. | 13.54 Million USD | -540.596% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -1664.671% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -33058.723% |
| SQZ Biotechnologies Company | 85.61 Million USD | -1.362% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -2875.926% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -5678.351% |
| Mesoblast Limited | 5.9 Million USD | -1370.434% |
| Marizyme, Inc. | 19.23 Million USD | -351.069% |
| Genus plc | 147.7 Million USD | 41.242% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -888.526% |
| Pharming Group N.V. | 225.49 Million USD | 61.513% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -4136.091% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -6369.034% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -940.712% |
| ContraFect Corporation | 56.88 Million USD | -52.551% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -1868.507% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -5768.8% |
| IMV Inc. | 37.7 Million USD | -130.143% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -3010.176% |
| MultiCell Technologies, Inc. | 567.42 USD | -15294567.09% |
| ONE Bio Corp. | 6.44 Million USD | -1246.779% |
| Accustem Sciences Inc. | 3.74 Million USD | -2216.479% |
| RVL Pharmaceuticals plc | 85.94 Million USD | -0.977% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -16214.135% |
| Q BioMed Inc. | 3.43 Million USD | -2425.295% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | -251.143% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -3202.922% |
| Biomind Labs Inc. | 994.18 Thousand USD | -8629.287% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 12.63% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -4831.868% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -1191.825% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -4554.924% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 347240.0% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | -442.059% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -4629.183% |
| GB Sciences, Inc. | 1.42 Million USD | -6009.43% |
| Alpha Cognition Inc. | 9.7 Million USD | -794.174% |
| HST Global, Inc. | 140.9 Thousand USD | -61490.269% |
| CSL Limited | 3.44 Billion USD | 97.484% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -7614.839% |
| Halberd Corporation | 74.84 Thousand USD | -115857.617% |
| Enzolytics Inc. | 2.17 Million USD | -3881.864% |
| Agentix Corp. | 1.37 Million USD | -6226.562% |
| Resverlogix Corp. | 12.71 Million USD | -582.701% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -2277.211% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 94.341% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -8212.739% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -3508.623% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -5394.965% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -2448.768% |
| AVAX Technologies, Inc. | 7.31 Million USD | -1087.166% |
| Zenith Capital Corp. | 8.94 Million USD | -870.424% |
| Genscript Biotech Corporation | 825.34 Million USD | 89.485% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -498063.136% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -3434.574% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -50500.843% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -4417.92% |
| Kadimastem Ltd | 2.41 Million USD | -3500.87% |
| Helix BioMedix, Inc. | 1.97 Million USD | -4300.786% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | -698.61% |
| BioStem Technologies, Inc. | 22.97 Million USD | -277.74% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -47719.379% |
| LadRx Corporation | 3.81 Million USD | -2176.751% |
| Cell Source, Inc. | 4.32 Million USD | -1906.429% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -9297.299% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -9297.299% |
| NovAccess Global Inc. | 2.46 Million USD | -3418.176% |
| Affymax, Inc. | 39.38 Million USD | -120.345% |
| Itoco Inc. | 919.14 Thousand USD | -9341.948% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -1947.582% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -7655.585% |
| Mobile Lads Corp. | 554.54 Thousand USD | -15549.739% |
| CytoDyn Inc. | 18.05 Million USD | -380.59% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -344709.091% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -39333.746% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -6012.515% |
| SYBLEU INC | 160.87 Thousand USD | -53845.275% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -4678.068% |
| International Stem Cell Corporation | 5.27 Million USD | -1546.462% |
| Bioxytran, Inc. | 3.82 Million USD | -2171.771% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -164758.858% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -426508.661% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | -139.301% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -5263.721% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -11694.084% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -2689.617% |
| Neutra Corp. | 243.82 Thousand USD | -35493.735% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | -397.136% |
| PureTech Health plc | 144.59 Million USD | 39.981% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | -323.55% |
| IXICO plc | 4.7 Million USD | -1743.743% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -886.529% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 26.296% |
| CSL Limited | 3.89 Billion USD | 97.771% |
| Cellectis S.A. | 97.32 Million USD | 10.825% |